Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma

NCT02987244 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

T Cell Non-Hodgkin's Lymphoma

Interventions

DRUG: Chidamide
DRUG: Cyclophosphamide
DRUG: Epirubicin
DRUG: Vindesine
DRUG: Etoposide
DRUG: Prednisone

Sponsor

Peking Union Medical College Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]